Helmut Schulte

Author PubWeight™ 33.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 2002 6.20
2 Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 2003 3.48
3 Prediction of risk of coronary events in middle-aged men in the Prospective Cardiovascular Münster Study (PROCAM) using neural networks. Int J Epidemiol 2002 2.48
4 Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM. Eur Heart J 2005 1.78
5 PROCAM Study: risk prediction for myocardial infarction using microfluidic high-density lipoprotein (HDL) subfractionation is independent of HDL cholesterol. Clin Chem Lab Med 2008 1.42
6 Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Am J Cardiol 2007 1.38
7 Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) study. Nutr Metab Cardiovasc Dis 2005 1.30
8 Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17. PLoS Genet 2006 1.29
9 Response to Conroy et al. SCORE Project. Eur Heart J 2003 1.20
10 Prevalence of cholesteryl ester storage disease. Arterioscler Thromb Vasc Biol 2007 1.11
11 Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study. Eur J Cardiovasc Prev Rehabil 2007 0.98
12 The impact of dietary fat composition on serum leptin concentrations in healthy nonobese men and women. J Clin Endocrinol Metab 2002 0.90
13 Gap between guidelines and practice: attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events Including Physicians' Experience and Evaluation). Eur J Cardiovasc Prev Rehabil 2006 0.88
14 Non-LDL-related dyslipidaemia and coronary risk: a case-control study. Diab Vasc Dis Res 2010 0.86
15 Cardiovascular risk assessment in metabolic syndrome: view from PROCAM. Endocrinol Metab Clin North Am 2004 0.84
16 Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease. Clin Endocrinol (Oxf) 2004 0.84
17 Genes, diet and public health. Genes Nutr 2007 0.83
18 The CAG repeat polymorphism in the androgen receptor gene is associated with HDL-cholesterol but not with coronary atherosclerosis or myocardial infarction. Clin Chem 2005 0.82
19 Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care. Curr Med Res Opin 2010 0.80
20 Relationship between phytosterol levels and components of the metabolic syndrome in the PROCAM study. Eur J Cardiovasc Prev Rehabil 2007 0.79
21 Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure. Clin Cardiol 2008 0.78
22 Interferences in coagulation tests--evaluation of the 570-nm method on the Dade Behring BCS analyser. Clin Chem Lab Med 2005 0.78
23 Evidence for oxidative stress at elevated plasma thiol levels in chronic exposure to carbon disulfide (CS2) and coronary heart disease. Nutr Metab Cardiovasc Dis 2006 0.76
24 Methods to identify increased risk of coronary disease in the general population: conclusion is oversimplification. BMJ 2003 0.75
25 "Polypill" to fight cardiovascular disease: interpretation of trial data is optimistic. BMJ 2003 0.75
26 Inflammation in atherosclerosis, not yet time for a paradigm shift? Curr Opin Lipidol 2003 0.75